ABBV vs ZTS
By Alex · Tickerpine
AbbVie Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ZTS |
|---|---|---|
| Price | $285.64 | $81.03 |
| Market cap | $504.76B | $33.48B |
| P/E ratio | 80.5 | 13.5 |
| ROE | — | 64.91% |
| Profit margin | 9.80% | 27.68% |
| Revenue growth | 10.20% | -0.20% |
| Dividend yield | 2.42% | 2.62% |
| Beta | 0.23 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ZTS in plain English
- ABBV is the bigger company — about 15.1× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 13.5 vs 80.5).
- ABBV is growing revenue faster (10% vs -0%).
- ZTS has the higher dividend yield (2.62% vs 2.42%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.